BALYASNY ASSET MANAGEMENT L.P. - MADRIGAL PHARMACEUTICALS INC ownership

MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 228 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.28 and the average weighting 0.4%.

Quarter-by-quarter ownership
BALYASNY ASSET MANAGEMENT L.P. ownership history of MADRIGAL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$4,118,912
+6995.5%
28,204
+14002.0%
0.01%
Q4 2022$58,050
-97.4%
200
-99.0%
0.00%
-100.0%
Q4 2018$2,254,00020,0000.02%
Other shareholders
MADRIGAL PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
HealthCor Management, L.P. 1,402,250$93,614,0004.00%
Parkman Healthcare Partners LLC 30,000$2,003,0000.93%
ARMISTICE CAPITAL, LLC 216,000$14,420,0000.89%
Avoro Capital Advisors LLC 349,000$23,299,0000.79%
Rock Springs Capital Management LP 250,000$16,690,0000.69%
Capital Impact Advisors, LLC 24,351$1,626,0000.68%
Baker Brothers Advisors 1,499,212$100,087,0000.62%
EWG Elevate Inc. 11,086$740,0000.56%
SHIKIAR ASSET MANAGEMENT INC 12,000$801,0000.54%
DAFNA Capital Management LLC 13,600$908,0000.38%
View complete list of MADRIGAL PHARMACEUTICALS INC shareholders